Summit Therapeutics (SMMT) Free Cash Flow (QoQ) (2017 - 2026)
Summit Therapeutics (SMMT) Free Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Summit Therapeutics | 10.47 Bn | 9.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.62% |
| Mar 31, 2026 | -25.75% |
| Dec 31, 2025 | -4.40% |
| Sep 30, 2025 | -36.15% |
| Jun 30, 2025 | -10.24% |
| Mar 31, 2025 | -22.08% |
| Dec 31, 2024 | -69.30% |
| Sep 30, 2024 | 8.25% |
| Jun 30, 2024 | -19.21% |
| Mar 31, 2024 | -42.27% |
| Dec 31, 2023 | -30.17% |
| Sep 30, 2023 | 48.96% |
| Jun 30, 2023 | -122.19% |
| Mar 31, 2023 | -353.49% |
| Dec 31, 2022 | 160.94% |
| Sep 30, 2022 | 56.25% |
| Jun 30, 2022 | -0.76% |
| Mar 31, 2022 | -108.22% |
| Dec 31, 2021 | 60.53% |
| Sep 30, 2021 | -21.92% |